Gsk Share Discussion Threads

[netcurtains] 12/10/2022 12:56

blimey Addullla how do you know this sort of stuff...

Will it finish the day BLUE or RED?

[abdullla] 12/10/2022 10:03

What about investors here sitting on a quarter of a million pounds paper losses,by the way GSK up 25p this morning will shortly be zero up .

[tradermichael] 12/10/2022 10:02

Ali, I don't think you are alone in that boat!

[alibizzle] 12/10/2022 08:24

As my shares in haleon and GSK have dropped in value by over 14k I need GSK to get back to around £18 or haleon to rise to around £5 , both seem unlikely so will sit on them for as long as it takes

[tradermichael] 12/10/2022 07:51

And this time last year, $1.40 = £1, now, £1.10 = £1

[patientcapital] 12/10/2022 07:38

Over 40% of earnings in a strong currency.

[charlie9038] 12/10/2022 07:37

Great time to add
gla

[netcurtains] 12/10/2022 07:36

Interesting

[tradermichael] 11/10/2022 06:41

And this year it's on Wednesday 2 November. Expect outstanding performance!

[berny3] 11/10/2022 06:28

27th October 2021 was when 3rd quarter results came out last year

[ridingthewaves1] 10/10/2022 18:32

When is next news expected here

[blackhorse23] 10/10/2022 08:25

RENE (LSE) produced ground breaking data , excellent

[tradermichael] 09/10/2022 16:45

Alp - yes, a good point. And these advanced antibody treatments potentially bring strong opportunities to extend to other therapies.

[alphorn] 09/10/2022 08:53

TM - To add to your post about late stage trials it should be noted that they can be used to increase potential patient exposure for later marketing (Phase IIIb trials) and Phase IV trials to explore more indications......... etc.

[tradermichael] 09/10/2022 08:04

The third phase of clinical trials typically lasts between one and four years. FDA Approval: Once Phase 3 has concluded, the company studying the drug can submit a New Drug Application (NDA) or a biologics license application (BLA) for the treatment to the Food and Drug Administration (FDA).

Finally, on Phase 4, after a product receives FDA approval and is on the market for consumers to use, further clinical trials may continue to gather more information on side effects, risks, benefits, and best uses. These studies are known as post-marketing surveillance (PMS) trials.

Phase 4 trials usually include hundreds to a few thousand participants.

[netcurtains] 08/10/2022 18:06

How many phases are normally after phase 3?
And how long has average phase 3 take?

Cheers Net.

[alphorn] 08/10/2022 17:33

'safety and tolerability profile' I would hope so - but does it work? That is the question.

[tradermichael] 08/10/2022 17:11

This is all you need to know:

GSK PLC on Wednesday said its drug for metastatic non-squamous non-small cell lung cancer Jemperli, or dostarlimab, is advancing to a phase 3 trial following positive results.

Jemperli is an antibody approved for the treatment of endometrial cancer in the US and EU.

Non-squamous means flat cells do not look like a fish scale under a microscope.

Citing its phase 2 Perla study, the Brentford, west London-based pharmaceuticals firm said that the safety and tolerability profile of dostarlimab was consistent with previous clinical trials of similar regimens.

Further, in its Costar phase 2/3 trial, now advancing to phase 3, GSK stated that the trial met its pre-specified expansion criteria per protocol.

"These trials support the ambition for dostarlimab to become the backbone of our ongoing immuno-oncology-based research and development programme when used alone and in combination with standard of care and future novel cancer therapies, particularly in patients with currently limited treatment options," said Hesham Abdullah, Senior Vice President & Global Head of GSK's Oncology Development arm.

[paul planet earth] 08/10/2022 15:40

'Forced Recession'..whats that all about!

[pol123] 08/10/2022 11:16

Forced recession in the US, works well for big Pharma for obvious reasons, strong dollar, resilient earnings I could go on. Makes GSK one of the best plays around IMO. I have recently stated we will be back to £15+ over the next 6 months. One caveat being Russia going nuclear

[tradermichael] 07/10/2022 10:49

Its entirely probable, given third quarter 2022 results on Wednesday 2 November.

These are expected to show a strong performance, especially with the strong dollar vs the weak pound.

[tuftymatt] 07/10/2022 09:53

That's a difficult one net as wider market conditions could keep it lower.
I think the company specific "bad news" has to be priced in so hopefully it slowly climbs back up. It would only need circa 3% a week from now to get to 1450 so it's possible.

[netcurtains] 07/10/2022 09:47

Do you think this might break through 1450 by November?

[paul planet earth] 06/10/2022 21:09

Try pressing filter button then tw@t!